Eko Health, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Eko Health, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Eko Health, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jul 23, 2026 to Jul 23, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code DQD appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 2100 Powell St., Suite 300, Emeryville, CA, 94608, US. Recorded on K261694, decision dated Jul 23, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CORE 300 Digital StethoscopeK261694 | Eko Health, Inc. | 510(k) clearance | Jul 23, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.
